Increase in overall mortality risk in patients with type 2 diabetes receiving different oral diabetes drugs
Реферат по статье: Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS. Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis. Diabetes Obes Metab. 2012...
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2012-12-01
|
Series: | Ожирение и метаболизм |
Online Access: | https://endojournals.ru/index.php/omet/article/view/5135 |
Similar Items
-
Initial glucose-lowering therapy and risks of overall and cardiovascular mortality, myocardial infarction and stroke in patients with type2 diabetes
by: Inna Vladimirovna Misnikova, et al.
Published: (2009-12-01) -
Increased Mortality Risk in People with Type 2 Diabetes Mellitus in Lithuania
by: Donata Linkeviciute-Ulinskiene, et al.
Published: (2020-09-01) -
Prehypertension increases the risk of atherosclerosis in drug-naïve Japanese patients with type 2 diabetes mellitus.
by: Ippei Kanazawa, et al.
Published: (2018-01-01) -
Risk of Alzheimer''s Disease among Type 2 Diabetic Patients Receiving Metformin
by: Hui-Wen Hsiao, et al.
Published: (2015) -
Type 2 diabetes, metformin and the risk of mortality in patients with prostate cancer
by: Bensimon, Leah
Published: (2014)